Skip to main content
. 2017 Apr 6;25(7):1491–1500. doi: 10.1016/j.ymthe.2017.03.001

Figure 1.

Figure 1

RNAi Delivery Strategies Available for Lymphocytes

(A) SNALP coated with specific ligand molecules encapsulated with siRNAs. (B) Apt-siRNA conjugate. (C) Cationic polymer-based nanoparticles encapsulated with plasmid DNA and siRNAs. (D) Single-chain variable fragment (scFv)-siRNA conjugate. (E) Antibody-protamine fusion protein-siRNA conjugate.